... → Israel's Sol-Gel Technologies' microencapsulation platform — designed to entrap active ingredients in porous silica microcapsules to address the ...
Sol-Gel's rosacea drug clears late-stage hurdle; uniQure's hemophilia gene therapy impresses with PhII data - Endpoints News
Read More
No comments:
Post a Comment